Cellares Automates Gene-Corrected HSPC Manufacturing
Cellares and Papillon will automate manufacturing and release testing for PPL-001, an autologous gene-corrected hematopoietic stem and progenitor cell therapy for Friedreich’s ataxia. The collaboration links a systemically distributed cell-based protein-delivery strategy with Cellares’…
